Analyst Caitlin Roberts of Canaccord Genuity maintained a Hold rating on InMode, retaining the price target of $15.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Caitlin Roberts’s rating is based on both improving fundamentals and lingering uncertainties that temper the upside case for InMode’s shares. The company’s latest quarterly results showed modest revenue growth that exceeded prior expectations, and management continues to emphasize more resilient segments such as lower-cost non-invasive treatments and wellness offerings, alongside new product launches and a more specialized sales force aimed at adapting to the current aesthetics market.
At the same time, Roberts highlights that leadership changes, including the CFO’s resignation and the Chairman’s departure without a named financial successor, introduce added execution and governance risk. Combined with ongoing geopolitical exposure from operations in the Middle East and a still-muted demand backdrop for higher-priced minimally invasive procedures, she prefers to see steadier financial performance and clearer visibility on management transitions before turning more constructive. As a result, she reiterates a Hold rating and keeps the price target unchanged at $15.
In another report released today, Robert W. Baird also maintained a Hold rating on the stock with a $14.00 price target.